Kinfo
Q/C Technologies, Inc. logo

Q/C Technologies, Inc.

QCLSNASDAQTechnology·US · USD
$0.33
+0.01 (+4.05%)
Prices as of November 17, 2026 · market closed

Price

Key statistics

Valuation
Market cap2.74M USD
Enterprise value-4.86M USD
Trailing P/E0.13
Forward P/E0.00
PEG ratio0.00
Price / sales0.00
Price / book0.17
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-33.44%
Return on equity-108.00%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-18.34M USD
Diluted EPS$2.62
Rev. growth (YoY)0.00%
Balance sheet
Total cash10.99M USD
Total debt371.17K USD
Debt / equity1.95
Current ratio3.29
Book value / share$1.95
Cash flow (TTM)
Operating cash flow-9.47M USD
Levered free cash flow-5.95M USD
Shares & price
Shares outstanding7.85M
Float7.90M
Held by institutions5.78%
Beta2.22
50-day MA$0.68
200-day MA$2.84
52-week high$8.17
52-week low$0.28
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-06-173.123.16+1.28%2026-06-080.330.49+48.48%2026-05-262.343.14+34.19%2026-04-171.001.09+9.00%
About Q/C Technologies, Inc.

Q/C Technologies, Inc. is a clinical-stage biopharmaceutical and computing technology company focused on developing therapeutic platforms and advanced energy-efficient computing solutions. Q/C Technologies operates through Pharmaceuticals and Computing Technology segments. In pharmaceuticals, the company develops Isomyosamine, a small molecule designed to regulate the immunometabolic system in conditions such as autoimmune disease, sarcopenia, frailty, rheumatoid arthritis, and inflammatory bowel disease, and Supera-CBD, a synthetic cannabidiol analog under development for epilepsy, pain, and anxiety or depression. In computing, Q/C Technologies is engaged in photonic and quantum-class computing concepts, including laser-based processing systems intended for high-performance applications in areas such as blockchain and cryptocurrency infrastructure. Headquartered in New York, Q/C Technologies positions itself at the intersection of biotechnology and next-generation computing, serving markets that span healthcare innovation and specialized digital infrastructure.

Sector
Technology
Industry
Computer Hardware
Employees
3
Headquarters
New York, NY, United States

Frequently asked questions about Q/C Technologies, Inc.